<DOC>
	<DOCNO>NCT02310100</DOCNO>
	<brief_summary>A prospective , multicenter , interventional study collect confirmatory evidence safety effectiveness TactiCath® percutaneous ablation catheter post approval set treatment symptomatic paroxysmal atrial fibrillation use contact force assist irrigated radiofrequency ablation .</brief_summary>
	<brief_title>TactiCath® Contact Force Ablation Catheter Study Atrial Fibrillation Post Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patient plan undergo catheter ablation procedure due symptomatic PAF refractory intolerant least one Class I IV antiarrhythmic drug 2 . Minimum one episode PAF great 30 second duration within 12 month prior enrollment document 12 lead electrocardiogram ( ECG ) , Holter monitor , transtelephonic event monitor , telemetry strip , implanted device 3 . Minimum 3 episode PAF within precede 12 month document patient history 4 . Patient 18 year age old 5 . Patient willing capable complying unassisted study protocol requirement include specify follow visit 6 . Patient provide write informed consent prior enrollment study 1 . Persistent longstanding persistent atrial fibrillation ( AF ) 2 . Patient 4 cardioversions past 12 month . 3 . Active systemic infection 4 . Presence implantable cardiac defibrillator ( ICD ) 5 . Arrhythmia due reversible cause include thyroid disorder , acute alcohol intoxication , major surgical procedure precede 3 month 6 . Myocardial infarction ( MI ) , acute coronary syndrome , percutaneous coronary intervention ( PCI ) , valve coronary bypass grafting surgery within precede 3 month 7 . Left atrial diameter &gt; 5.0 cm 8 . Left ventricular ejection fraction &lt; 35 % 9 . New York Heart Association ( NYHA ) class III IV 10 . Previous leave atrial ablation procedure , either surgical catheter ablation 11 . Patient leave atrial surgical procedure incision result scar 12 . Previous tricuspid mitral valve replacement repair 13 . Heart disease corrective surgery anticipate within 6 month 14 . Bleeding diathesis suspect pro coagulant state 15 . Contraindication long term antithromboembolic therapy 16 . Presence condition precludes appropriate vascular access 17 . Renal failure require dialysis 18 . Known sensitivity contrast medium ( needed procedure ) control premedication 19 . Contraindication compute tomography magnetic resonance angiography 20 . Severe pulmonary disease ( e.g. , restrictive pulmonary disease , constrictive chronic obstructive pulmonary disease ) disease malfunction lungs respiratory system produce severe chronic symptom 21 . Positive pregnancy test result female patient childbearing potential 22 . Patient anatomic co morbid condition , investigator 's opinion , could limit patient 's ability participate study comply follow requirement , impact scientific soundness study result 23 . Patient currently participate another clinical trial participate clinical trial within 30 day prior screen may interfere study 24 . Patient unlikely survive protocol follow period 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>